image
Neurocrine Biosciences, Inc. NBIX
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
Watchlist
$ 117.44
-4.42 %
$ 11.9 B
Market Cap
31.32
P/E
INCOME STATEMENT
1.89 B REVENUE
26.76%
Growth Rates
1Year 26.76%
3Years 21.74%
5Years 33.13%
7Years 99.51%
10Years 91.01%
251 M OPERATING INCOME
0.76%
Growth Rates
1Year 0.76%
3Years -7.68%
5Years 46.73%
7Years 20.56%
10Years 21.57%
250 M NET INCOME
61.62%
Growth Rates
1Year 61.62%
3Years -15.05%
5Years 63.90%
7Years 20.87%
10Years 22.19%
EFFICIENCY
Earnings Waterfall Neurocrine Biosciences, Inc.
image
Revenue 1.89 B
Cost Of Revenue 39.7 M
Gross Profit 1.85 B
Operating Expenses 1.6 B
Operating Income 251 M
Other Expenses 1.2 M
Net Income 250 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996
REVENUE
Revenue 1 887.1 1 488.7 1 133.5 1 045.9 788.1 451.2 161.6 15.0 19.8 0 2.9 53.1 77.4 33.5 3.0 4.0 1.2 39.2 123.9 85.2 139.1 18.0 41.2 14.6 16.8 16.0 26.1 19.2
GROSS PROFIT
Cost Of Revenue 39.7 23.2 14.3 10.1 7.4 4.9 1.3 35.9 33.8 14.4 13.8 11.6 0 0 0 0 0 0 0 0 0 0 0 (2.2) (2.1) (1.7) (1.3) (1.0)
Gross Profit 1 847.4 1 465.5 1 119.2 1 035.8 780.7 446.4 160.4 (20.9) (14.0) (14.4) (10.9) 41.5 77.4 33.5 3.0 4.0 1.2 39.2 123.9 85.2 139.1 18.0 41.2 16.8 18.9 17.7 27.4 20.2
OPERATING INCOME
Operating Expenses 1 596.5 1 216.5 911.4 708.3 554.1 409.5 291.7 162.4 114.0 64.4 52.6 51.7 43.4 47.2 50.6 91.3 213.5 152.6 149.0 137.5 197.9 121.7 85.1 52.4 38.8 30.1 26.9 17.3
Selling, General and Administrative Expenses 887.6 752.7 583.3 433.3 354.1 248.9 169.9 68.1 32.5 18.0 13.3 13.4 12.5 16.1 14.8 20.2 37.5 54.9 42.3 22.4 20.6 12.7 10.9 10.0 7.5 6.6 5.7 3.7
Research and Development Expenses 565.0 463.8 328.1 275.0 200.0 160.5 121.8 94.3 81.5 46.4 39.2 37.2 31.0 31.2 35.8 55.3 82.0 97.7 106.6 115.1 177.3 108.9 74.3 40.2 29.2 21.8 19.9 12.6
Operating Income 250.9 249.0 196.9 318.9 219.1 36.9 (131.4) (147.4) (94.2) (64.4) (49.7) 1.4 33.9 (13.7) (53.7) (87.3) (212.2) (113.3) (25.1) (52.3) (58.8) (103.6) (43.9) (35.6) (19.9) (12.4) 0.5 2.9
PRE-TAX INCOME
Interest Income Expense 4.6 7.1 25.8 32.8 32.0 30.5 19.5 0 0 0 0 0 0 0 0 7.0 (3.9) (3.7) (4.2) (2.0) (0.5) (0.5) 0 0 0 0 0 0
Total Other Income 81.2 (35.1) (1.1) (56.3) (25.8) (15.1) (11.2) 6.3 5.3 3.9 3.6 3.6 3.6 5.8 2.6 (1.3) 4.9 6.1 2.9 6.6 28.7 9.1 7.1 7.1 0.2 (7.4) 4.8 3.2
Pre-Tax Income 332.1 213.9 101.4 106.7 46.5 21.8 (142.5) (141.1) (88.9) (60.5) (46.1) 5.0 37.6 (8.0) (88.6) (88.6) (207.3) (107.2) (22.2) (45.7) (30.1) (94.5) (36.8) (28.5) (19.7) (19.8) 5.3 6.1
NET INCOME
Tax Provision 82.4 59.4 11.8 (300.6) 9.5 0.7 17.1 (7.7) (6.3) (4.7) (4.2) (4.2) (4.3) 0 0.2 1.3 (4.9) 0 0 79 K 0.2 (9.1) 0.1 0.3 (3.1) 7.6 0.2 0.2
Net Income 249.7 154.5 89.6 407.3 37.0 21.1 (142.5) (141.1) (88.9) (60.5) (46.1) 5.0 37.6 (8.0) (51.0) (88.6) (207.3) (107.2) (22.2) (45.8) (30.3) (94.5) (36.9) (28.8) (16.8) (20.0) 5.1 5.9
EPS 2.56 1.61 0.95 4.37 0.4 0.22 1.62 1.63 1.05 0.81 0.69 0.0766 0.68 0.15 1.3 2.3 5.45 2.84 0.6 1.26 0.93 3.1 1.42 1.3 0.88 1.1 0.3 0.39